The study shows that sEV from diabetic, obese, and ischemic patients have different angiogenic capabilities, but the underlying mechanisms driving these population-specific differences remain unexplained. Understanding these mechanisms is critical for developing personalized sEV-based therapies. Gap type: unexplained_observation Source paper: miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential. (2020, Scientific reports, PMID:31959759)
Landscape Summary: What molecular mechanisms cause sEV angiogenic properties to vary between different cardiovascular risk populations? is a 0.8 priority gap in cardiovascular-biology. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What molecular mechanisms cause sEV angiogenic properties to vary between different cardiovascular risk populations? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: